SCHEMBL10039738

SCHEMBL10039738

CC1(C(=O)N2CCN(C(=O)c3cc(Cc4n[nH]c(=O)c5ccccc45)cc4c3OCC4)CC2)CCCN1

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 20/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10039744 1.00 PARP1 (0.61) PARP1
SCHEMBL10039819 1.00 PARP1 (0.61) PARP1
SCHEMBL10039750 0.87 PARP1 (0.61) PARP1
SCHEMBL10039739 0.87 PARP1 (0.65) PARP1
SCHEMBL10039732 0.87 PARP1 (0.63) PARP1
SCHEMBL10039784 0.87 PARP1 (0.65) PARP1
SCHEMBL10039730 0.87 PARP1 (0.63) PARP1
SCHEMBL10039680 0.86 PARP1 (0.64) PARP1
SCHEMBL10039753 0.86 PARP1 (0.66) PARP1
SCHEMBL10039693 0.86 PARP1 (0.62) PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012019430-A1 PHTHALAZINONE DERIVATIVE, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-02-16 — — WO disclosed
Send feedback